№ lp_1_2_11989
File format: docx
Character count: 9691
File size: 95 KB
The document is a survey intended to assess the acceptability of HIV Point-of-Care Nucleic Acid Tests (NATs) among participants of the GAIN study, focusing on their experiences and the accuracy of the results received during their visits.
Year:
N/A
Region / City:
N/A
Topic:
HIV Diagnosis, HIV Prevention
Document Type:
Survey
Organization / Institution:
CDC
Author:
N/A
Target Audience:
Participants of the GAIN Study
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Year:
2026
Region / City:
Canberra, Australia
Subject:
Blood glucose and ketone point-of-care testing
Document Type:
Procedure
Organization:
Canberra Health Services (CHS)
Intended Users:
Medical Officers, Nurses and Midwives, Allied Health Professionals, Students under supervision
Equipment:
Nova Statstrip XpressTM meter
Scope:
Inpatient facilities and community services of CHS Network
Compliance:
Internal Quality Control, External Quality Assurance Programme (EQAP)
Safety Measures:
Standard precautions and infection control procedures
Record Keeping:
Quality Control Logbook, EQAP reports retention
Year:
2026
Region:
Not specified
Document type:
Supplementary material / Research data
Methods:
LC-MS/MS, IP–HILIC–MS/MS
Analytes:
Tenofovir (TFV), Tenofovir-diphosphate (TFV-DP)
Sample types:
Urine, Dried Blood Spots (DBS)
Target population:
Participants on antiretroviral therapy (ART)
Measured variables:
Urine TFV concentration, DBS TFV-DP concentration, POC TFV results, self-reported adherence, viral load, drug resistance
Instrument:
Agilent HPLC coupled to AB Sciex 5500 triple quadrupole mass spectrometer
Software:
Analyst v1.6.2
Detection method:
Negative-ion multiple reaction monitoring (MRM)
Tables included:
S1, S2, S3, S4
Year:
2013
Region / City:
International
Subject:
Veterinary clinical pathology; Point-of-care testing quality assurance
Document Type:
Guideline / Compliance checklist
Organization:
American Society for Veterinary Clinical Pathology (ASVCP)
Authors:
Bente Flatland, Kathleen P. Freeman, Linda M. Vap, Kendal E. Harr
Target Audience:
Veterinary laboratories, clinical pathologists, veterinary diagnostic personnel
Version:
1.0
Date of Publication:
May 2013
Reference Links:
www.asvcp.org
Institution:
Xi’an Jiaotong-Liverpool University, China
School:
School of Advanced Technology
Project Title:
Paper-based microfluidic devices for point-of-care disease diagnosis 全自动、快速微流控纸基生物传感器的研究与开发
Supervisors:
Dr. Pengfei Song (Principal Supervisor, XJTLU); Dr. Chunfeng Yue (JITRI); Dr. Kai Hoettges (University of Liverpool)
Degree Awarding Body:
University of Liverpool, United Kingdom
Funding Type:
Funded PhD project
Funding Coverage:
Tuition fees for three years (RMB 80,000 per annum) and monthly living allowance of RMB 3000 during research at Micro-Nano Automation Institute
Duration:
Three years (subject to satisfactory progress)
Application Deadline:
Open until the position is filled
Location of Research:
Suzhou, China
Collaborating Institutions:
XJTLU and Jiangsu Industrial Technology Research Institute (Micro-Nano Automation Institute)
Research Field:
Paper-based microfluidics; point-of-care diagnostics; biomedical engineering
Project Focus:
Development of automated μPAD platform for rapid detection of COVID-19 and influenza antigen markers
Eligibility Criteria:
First class or upper second class honours degree or master’s degree in relevant engineering disciplines
English Language Requirement:
IELTS 6.5 or above (if first language is not English)
Application Materials:
CV; two reference letters; personal statement; proof of English proficiency; verified transcripts and certificates; Master’s dissertation or equivalent writing sample
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Course Code:
NATS 1510
Course Title:
History of the Environment
Discipline:
Environmental History
Focus:
Human impact on the environment through science and technology
Institution:
York University
Instructor:
Dr. Ian Slater
Contact Email:
[email protected]
Lecture Time:
Mondays, 7–10
Lecture Location:
LAS C
Office Hours:
TBA
Required Texts:
Online
Submission Method:
Moodle
Assessment Components:
Reading Summary and Critique (15%), Annotated Bibliography (15%), Essay (40%), Final Exam (30%)
Assignment Deadlines:
October 3; November 7; December 5
Exam Type:
Cumulative Final Exam
Chronological Scope:
Earliest human civilizations to present day
Key Themes:
Anthropogenic impacts; science and technology; environmental responsibility; pollution; green technology; environmental models and testing; corporate capitalism and technology
Course Format:
Weekly lectures with assigned readings
Year:
2026
Region / City:
Rockland
Topic:
Hockey Tournament Rules
Document Type:
Tournament Rules
Organization / Institution:
Hockey Canada, HEO
Author:
Tournament Committee
Target Audience:
U11 Hockey Teams and Coaches
Period of Effect:
2026
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2026
Region / City:
Rockland
Subject:
Hockey Tournament Rules
Document Type:
Tournament Rules
Organization:
Hockey Canada, HEO
Author:
Tournament Coordinator / Committee
Target Audience:
Teams, Players, Coaches
Period of Validity:
Tournament dates
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Note:
Year
Subject:
Biosafety, Recombinant Nucleic Acids, Synthetic Nucleic Acids, Biohazardous Materials
Document Type:
Registration Form
Institution:
Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago
Target Audience:
Researchers conducting experiments involving recombinant or synthetic nucleic acids or biohazardous materials
Journal:
Nucleic Acids Research
Type of document:
Manuscript template
Intended audience:
Authors submitting to the journal
Sections included:
Abstract, Introduction, Materials and Methods, Results, Discussion, Graphical Abstract, Data Availability
Formatting requirements:
Font, layout, file type, resolution, orientation
Authorship instructions:
Guidelines for corresponding authors, joint authorship, present addresses, groups and consortia
Graphical abstract requirements:
Size, file type, resolution, content specifications
Submission instructions:
Removal of template instructions before submission
Content guidance:
Title clarity, avoidance of jargon, abstract limitations
Source type:
Academic journal manuscript template
Organization:
Institutional Biosafety Committee (IBC), Ann & Robert H. Lurie Children’s Hospital of Chicago
Document Type:
Administrative Form
Purpose:
Inactivation of an approved biosafety research protocol after project completion
Subject Area:
Biosafety and Biohazardous Research Oversight
Related Activities:
Research involving recombinant and synthetic nucleic acid molecules and biohazardous materials
Submission Method:
E-mail submission to [email protected]
Responsible Role:
Principal Investigator (PI)
Compliance Reference:
NIH Guide for the shipment and transfer of recombinant and synthetic nucleic acids
Key Declarations:
Confirmation of project completion, biosafety compliance, disposal of biohazards, and proper storage of biological agents
Required Fields:
Date of report, biosafety registration number, protocol title, PI name, PI email, investigator signature, date
Approval Authority:
Institutional Biosafety Committee
Year:
2026
Institution:
National Institutes of Health (NIH)
Type of Document:
Guidance / Regulatory Summary
Subject:
Recombinant DNA (rDNA) and Synthetic DNA (sDNA) research
Author:
NIH Office of Biotechnology Activities (OBA)
Target Audience:
Researchers using NIH funds, Institutional Biosafety Committees
Scope:
United States, applicable to institutions receiving NIH funding
Regulatory References:
NIH Guidelines, CDC Select Agent Program, BMBL Manual
Compliance Requirements:
Institutional Biosafety Committee (IBC) approval, RAC review, IRB approval for human research, adherence to biosafety and waste management protocols
Publication Date:
2026
Website Reference:
http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines
Year:
2023
Region / City:
Global
Theme:
Scientific Research, Nucleic Acids
Document Type:
Manuscript Template
Organization / Institution:
Nucleic Acids Research
Author:
Not specified
Target Audience:
Researchers, Scientists
Validity Period:
Ongoing
Approval Date:
Not provided
Modification Date:
Not provided